These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8983296)

  • 21. Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer.
    Skowronek J; Piotrowski T; Zwierzchowski G
    Brachytherapy; 2004; 3(2):87-94. PubMed ID: 15374540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
    Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
    Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
    Sur RK; Donde B; Levin VC; Mannell A
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined external and intraluminal radiotherapy in the treatment of advanced oesophageal cancer.
    Hujala K; Sipilä J; Minn H; Ruotsalainen P; Grenman R
    Radiother Oncol; 2002 Jul; 64(1):41-5. PubMed ID: 12208574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience].
    Gava A; Fontan L; Bolner A; Botturi M; Cafaro I; Di Marco A; Marazzato G; Muto P; Orecchia R; Orsatti M; Parisi SS; Rigon A
    Radiol Med; 1996; 91(1-2):118-21. PubMed ID: 8614712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer].
    Patonay P; Naszály A; Mayer A
    Strahlenther Onkol; 2007 Feb; 183(2):94-8. PubMed ID: 17294114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
    Morton G; Loblaw A; Cheung P; Szumacher E; Chahal M; Danjoux C; Chung HT; Deabreu A; Mamedov A; Zhang L; Sankreacha R; Vigneault E; Springer C
    Radiother Oncol; 2011 Sep; 100(3):463-7. PubMed ID: 21924511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer.
    Freiberger C; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
    Brachytherapy; 2018; 17(3):517-523. PubMed ID: 29496423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iridium-192 high dose rate brachytherapy combined with external beam irradiation in non-resectable oesophageal cancer.
    Pakisch B; Kohek P; Poier E; Stücklschweiger G; Poschauko J; Raith J; Quehenberger F; Mayer R; Hackl A
    Clin Oncol (R Coll Radiol); 1993; 5(3):154-8. PubMed ID: 7688549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
    Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
    Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
    Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
    Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of multiparametric transrectal ultrasound-based focal high-dose-rate dose escalation combined with supplementary external beam irradiation in intermediate- and high-risk localized prostate cancer patients.
    Kovács G; Müller K; Soror T; Melchert C; Guo X; Jocham D; Merseburger A
    Brachytherapy; 2017; 16(2):277-281. PubMed ID: 27964906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
    Chang LF; Horvath J; Peyton W; Ling SS
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of radical external beam radiotherapy versus external beam radiotherapy combined with intraluminal brachytherapy for primary esophageal cancer.
    Ye M; Han D; Mao Z; Cheng G
    Brachytherapy; 2022; 21(5):703-711. PubMed ID: 35787969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.